ImageneBio (IMA) Gains from Investment Securities (2020 - 2025)

ImageneBio has disclosed Gains from Investment Securities across 6 years of filings, most recently posting $536430.0 for Q3 2025.

• Gains from Investment Securities for Q3 2025 came in at $536430.0, down 77.43% year-over-year; the trailing twelve-month figure through Sep 2025 was $536430.0 (down 77.43% YoY), and the FY2024 annual result was $485555.0, down 93.15% from the prior year.
• Gains from Investment Securities came in at $536430.0 for Q3 2025 at ImageneBio, down from $1.3 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $7.4 million in Q3 2023 to a low of -$100000.0 in Q4 2024.
• The 5-year median for Gains from Investment Securities is $1.5 million (2022), against an average of $2.4 million.
• Across the five-year window, Gains from Investment Securities sank 131.51% in 2024 and soared 1249.92% in 2025, its largest moves.
• ImageneBio's Gains from Investment Securities stood at $1.2 million in 2021, then surged by 458.45% to $6.7 million in 2022, then gained by 10.68% to $7.4 million in 2023, then plunged by 101.35% to -$100000.0 in 2024, then soared by 636.43% to $536430.0 in 2025.
• The last three Gains from Investment Securities figures came in at $536430.0 (Q3 2025), $1.3 million (Q2 2025), and $1.1 million (Q1 2025), per Business Quant data.